AG942020: Galα(1,3)LacNAc-β-Butyl-Carboxylic Acid Pack Size:1 mg 5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonate)-(2→3)-2

5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonate)-(2→3)-2

32 / A β-D-N-acetylglucosamine (GlcNAcβ) ligand equipped with a terminal carboxylic acid through a short butyl spacer

C44H51NO22 / 945

β-D-LacNAc-C4-COOH

C13H23NO8 / 321

AG942020: Galα(1,3)LacNAc-β-Butyl-Carboxylic Acid Pack Size:1 mg 5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranosylonate)-(2→3)-2C25H43NO18 645. 6 A Gal1 3LacNAc ( Gal epitope) ligand equipped with a terminal carboxylic acid through a short butyl spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl (PFP) esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form stable amide bonds. This compound presents a terminal Gal1 3 linkage on a LacNAc core, corresponding to the Gal epitope (Gal1 3Gal1